AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06209645 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tACS (Transcranial Alternating Current Stimulation)
Description: The tACS group will be treated with non-invasive motor cortex stimulation. The stimulation series comprises six sessions spaced 2 weeks apart, the first session being placebo. A two-minute EEG recording will be made before each session, using the same electrodes as for stimulation. Stimulation frequency will be set according to the dominant frequency recorded over the motor area. Anodal stimulation of 2,0 mA will be delivered over the motor area contralateral to the painful region (C4 or C3 according to the international 10-20 system). The return electrode will be placed over the fronto-polar region (FP1 or FP2) ipsilateral to the painful region.
Study NCT05736107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBL-514 Injection
Description: Formulated as an injectable CBL-514 solution at a concentration of 5 mg/mL.
Study NCT05736107 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% Sodium Chloride
Description: Sodium Chloride (0.9% NaCl) placebo for injection
Study NCT06387745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hepatoscope
Description: The Hepatoscope is a non-invasive external ultrasound imaging device, intended for general purpose pulse echo ultrasound imaging, and soft tissue elasticity imaging of the human body. In addition, the Hepatoscope provides measurements of shear wave speed and tissue stiffness, ultrasound beam attenuation and estimates of speed of sound, in internal structures of the body.
Study NCT05814939 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VC005 tablets
Description: VC005 groups repeat administration for 12 weeks
Study NCT05814939 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tofacitinib Citrate Tablets
Description: Tofacitinib Citrate groups repeat administration for 12 weeks
Study NCT05814939 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VC005 Tablets Placebo
Description: VC005 placebo groups repeat administration for 12 weeks
Study NCT05482763 — intervention group
Intervention type: DRUG
Intervention: Terbinafine Topical Gel
Description: Topical application of terbinafine
Study NCT05482763 — intervention group
Intervention type: DRUG
Intervention: Itraconazole 200 mg
Description: systemic itraconazole pulse therapy
Study NCT05482763 — intervention group
Intervention type: DRUG
Intervention: Terbinafine 250 mg
Description: systemic terbinafine
Study NCT05482763 — intervention group
Intervention type: DRUG
Intervention: Ciclopirox Topical Gel
Description: Topical application of ciclopirox
Study NCT05482763 — intervention group
Intervention type: DRUG
Intervention: Amorolfine 50 MG/ML
Description: Topical application of amorolfine
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Quality of life assessment
Description: Quality of life assessment; It will be evaluated with the Nottingham Health Profile.
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Lower extremity muscle strength assessment
Description: Lower extremity muscle strength assessment; It will be evaluated with a 30-second sit-and-stand test.
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Hand grip strength measurement test
Description: Hand grip strength measurement test; It will be evaluated with a dynamometer.
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Pulmonary function assessment
Description: Pulmonary function assessment; It will be evaluated by spirometry.
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Balance assessment
Description: Balance assessment will be done with the Wii Fit Balance Board.
Study NCT06455111 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Keenoa
Description: Keenoa is an artificial intelligence-enhanced, image-assisted tool, is a newly designed mobile application that may facilitate collection of dietary data. Serving as a visual food diary, individuals can upload a picture of their meal, choose the food items eaten using a preselected food list available by the app, and confirm the portion size with the presented visual aids.
Study NCT06455111 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ASA24
Description: The Automated Self-Administered 24-Hour (ASA24) dietary recall or record is a free, web-based tool that enables multiple, automatically coded, self-administered 24-hour diet recalls and/or single or multi-day food records, also known as food diaries.
Study NCT06685757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Felzartamab
Description: Participants will receive felzartamab by intravenous infusion.
Study NCT06685757 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive 0.9% saline solution by intravenous infusion.
Study NCT06477614 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DC cell Vaccine
Description: Deliver DC cell vaccine into patients for anti-ancer therapy.
Study NCT06088576 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Together
Description: Tchat : limited to 20-30 minutes per day. With a member of the team Together. For teleconsultations : First teleconsultation, during the first month (1 to 4 sessions/month), are made by nurse and/or educator. After that, it is psychologists who do the teleconsultations (2 to 4 sessions/month). It's during 30 to 45 minutes.~Home visits, individual or group interviews on site are possible after 4 month.
Study NCT06757816 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: accessory rod and iliac fixation for distal augmentation for S1 fixation.
Description: patients who were admitted to the spine unit and needed extension of fixation for L5 S1 fusion due to failed previous surgery, instability, or degenerative changes ,infection, tumors and pseudoarthrosis.
Study NCT06316141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aqua Jogging
Description: This group performed aqua jogging for 60 minutes consisting of 10 minutes warming up, 40 minutes aqua jogging or land jogging and 10 minutes cooling down.
Study NCT06762327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ensartinib
Description: ensartinib 225mg ,PO,QD,until disease progression or intolerable toxicity
Study NCT06762691 — intervention group
Intervention type: DEVICE
Intervention: MyCRO Band
Description: A 3D-printed cranial remolding orthosis
Study NCT06762691 — intervention group
Intervention type: DEVICE
Intervention: Traditional CRO
Description: A traditionally manufactured cranial remolding orthosis such as the Orthomerica Starband
Study NCT06761183 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: intracerebral stereotactic injection of NXL-001
Description: intracerebral stereotactic injection of NXL-001: with 3 subjects in each group to receive a single stereo-tactically intracerebral injection of NXL-001 at escalating doses.
Study NCT06761027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib combined with Sintilimab
Description: Based on the mFOLFIRINOX chemotherapy regimen, combined with the safe dose of anlotinib determined in phase Ib and sintilimab.
Study NCT06316141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Land based Jogging
Description: This group performs land jogging for 60 minutes consisting of 10 minutes warming up, 40 minutes aqua jogging or land jogging and 10 minutes cooling down.
Study NCT06762041 — intervention group
Intervention type: DRUG
Intervention: Metformin treatment
Description: Interested subjects with autism are treated with metformin with a standard dosage
Study NCT06762574 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low Level Laser Therapy
Description: Low Level Laser Therapy sometimes known as Low Level Light Therapy or Photobiomodulation (PBM) is a low intensity light therapy. The effect is photochemical not thermal. The light triggers biochemical changes within cells and can be compared to the process of photosynthesis in plants, where the photons are absorbed by cellular photoreceptors and triggers chemical changes.
Study NCT06762574 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Low Level Laser Therapy
Description: Placebo Low Level Laser Therapy:turning on the device with covering probe by aluminum foil and ask patient to wear sun glasses to obtain the placebo effect.
Study NCT06760910 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS Stimulation
Description: Anode tDCS or sham stimulation for amblyopia of Adolescents
Study NCT06760910 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: tDCS Stimulation
Description: Anode tDCS or sham stimulation for amblyopia of Adolescents
Study NCT06760910 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Anodal tDCS
Description: Anodal tDCS
Study NCT05350800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986369
Description: Specified dose on specified days
Study NCT06760910 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Sham tDCS
Study NCT05974657 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Probiotic Lactobacillus acidophilus LA85
Description: Through a randomized double-blind placebo-controlled method, the patients were randomly divided into placebo group and probiotic intervention group, and took probiotics once a day for 14 consecutive days.
Study NCT05974657 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic Lactobacillus acidophilus LA85
Description: Through a randomized double-blind placebo-controlled method, the patients were randomly divided into placebo group and probiotic intervention group, and took probiotics once a day for 14 consecutive days.
Study NCT06397157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Participants will recieve treatment(Virtual reality) for every alternate day (3 days per week) for 6 weeks. Total number of sessions will be 18.
Study NCT06397157 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality
Description: Participants will recieve treatment(Virtual reality) for every alternate day (3 days per week) for 6 weeks. Total number of sessions will be 18.
Study NCT04709016 — intervention group
Intervention type: BEHAVIORAL
Intervention: self-questionnaire
Description: self-questionnaire assessing Chemsex's (drug use in a sexual context) consumption over the last 12 months
Study NCT05742438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine IV
Description: Continuous intravenous infusion of lidocaine
Study NCT06397157 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motor Imagery
Description: Participants will recieve treatment(Motor Imagery) for every alternate day (3 days per week) for 6 weeks. Total number of sessions will be 18.
Study NCT06397157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Imagery
Description: Participants will recieve treatment(Motor Imagery) for every alternate day (3 days per week) for 6 weeks. Total number of sessions will be 18.
Study NCT06397157 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine Physical therapy
Description: Participants will recieve treatment(Routine physical therapy) for every alternate day (3 days per week) for 6 weeks. Total number of sessions will be 18.
Study NCT06397157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physical therapy
Description: Participants will recieve treatment(Routine physical therapy) for every alternate day (3 days per week) for 6 weeks. Total number of sessions will be 18.
Study NCT05530044 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social diffusion intervention
Description: training in communication skills
Study NCT05530044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social diffusion intervention
Description: training in communication skills
Study NCT05176002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Neoadjuvant Camrelizumab combined with radiotherapy
Study NCT05742438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine IV
Description: Continuous intravenous infusion of dexmedetomidine
Study NCT05742438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intrathecal morphine
Description: intrathecal morphine injection
Study NCT06386133 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MS Boost
Description: remote monitoring digital tool based on functional tests (walking, dexterity, vision and cognition). These digital tests may be combined with a fatigue assessment via questionnaires and, if needed, a telerehabilitation program. This program includes an algorithm comprising fatigue management advice and/or physical activity recommendations personalised to the patients, aimed at improving fatigue-related symptoms. The patient can use the telerehabilitation program without supervision
Study NCT06386133 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: General fatigue tips are given to patients who suffering from chronic fatigue such as stop smoking, eat a healthy diet...
Study NCT05605392 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Deinstitutionalization process
Description: Phase 1: Comprehensive geriatric assessment to evaluate who might be a candidate for deinstitutionalization.~Phase 2: Intervention:~1. Support plan: design a plan agreed upon with the participant to provide resources to the person's needs and which guarantees support during the transition and beyond.~2. Transition process: progressive withdrawal of support in the institution and implementation of support and adaptation in the community, with different types of accommodation depending on the needs and preferences of each participant. Coordination with primary care teams, social services, and other community resources.~3. Case follow-up and gradual withdrawal of the project team. If the process does not go as the person expects, or difficulties are encountered that cannot be resolved, the participant will have the option and choice, if desired, to return to the residence at any time during the process.
Study NCT06192186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab combined with SOX regimen
Description: Adebrelimab combined with SOX regimen preoperatively used 3 cycles(stop adebrelimab and S-1/oxaliplatin after 3 cycles and evaluate tumor staging)→ radical surgery (D2) →Postoperative selection of continued medication or cessation of treatment will base on the patient's pathological reports. Surgery should be performed within 3-6 weeks after 3 cycles of preoperative neoadjuvant therapy.
Study NCT06192186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo combined with SOX (S-1/oxaliplatin) regimen
Description: Placebo combined with SOX (S-1/oxaliplatin) regimen preoperatively used 3 cycles (stop placebo and S-1/oxaliplatin after 3 cycles and evaluate tumor staging) → radical surgery (D2) →Postoperative selection of continued medication or cessation of treatment will base on the patient's pathological reports. Surgery should be performed within 3-6 weeks after 3 cycles of preoperative neoadjuvant therapy.
Study NCT05422014 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Life Care Specialist (LCS)
Description: Life Care Specialist (LCS) will :~* Provide patients with individualized risk assessment for opioid misuse.~* Act as patient's Pain Coach. Providing targeted education and behavior-based pain treatment options.~* Train and provide CWC evidence based non-pharmaceutical pain management techniques, using the Community Resiliency Model.~* Use the Opioid Risk Tool (ORT) as the method to identity the risk of substance misuse.~* Provide education, support and resources, as well as local, state, and national resources to enhance the whole health aspect of the position. These resources include but are not limited to: written documents that outline the key concepts of the pain management techniques taught by the LCS and a list of hotlines and websites.~* LCS, when applicable, will provide education for caretakers on the risk of opioid use and the non -pharmaceutical pain management protocol.~* Provide follow up for all patients in intervention group.
Study NCT05266183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simultaneous Variety
Description: 3 different foods served
Study NCT05266183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single-Food
Description: 1 food served
Study NCT05266183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Small Portion
Description: Small meal portion size
Study NCT05266183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Large Portion
Description: Large meal portion size
Study NCT04226456 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine
Description: Injection of a 10% solution of N-acetylcysteine through transtympanic injection in both ears
Study NCT04248972 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBM
Description: A whole body red light therapy (NovoTHOR®) will be carried out during 20 minutes
Study NCT04248972 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO PBM
Description: A placebo whole body red light will be carried out during 20 minutes
Study NCT05466240 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AT-752
Description: AT-752 for 5 days
Study NCT04841759 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: 8 week exercise program, nutritional \& psychological consultation
Study NCT05466240 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo for 5 days
Study NCT04841759 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 8 week exercise program, nutritional \& psychological consultation
Study NCT05357664 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Total Hip Arthroplasty
Description: Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
Study NCT05357664 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revision Total Hip Arthroplasty
Description: Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
Study NCT05540769 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: catheter guided ASD closure
Description: transcatheter secundum ASD device closure
Study NCT06178536 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Consumption
Description: The surgery will be done using a bone consumption protocol
Study NCT06178536 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Consumption
Description: The surgery will be done using a bone consumption protocol
Study NCT06178536 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone expansion
Description: implants will be placed after a bone expansion protocol
Study NCT06178536 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone expansion
Description: implants will be placed after a bone expansion protocol
Study NCT05199506 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAP
Description: Treatment of cellulite with RAP device
Study NCT05548049 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bone harvesting from ramus area with piezosurgery for autogenous bone augmentation
Description: In this invervention, the piezo-surgical device settings were set to irrigation: '4', function: 'cortical', light: 'auto'. After the full-thickness flap was lifted with the periosteal elevator, superior and vertical osteotomies were performed with the OT-12 piezo-surgical tip. Lower horizontal osteotomies were performed using OT8-L or OT-8-R piezo tips according to the studied quadrant, combining the vertical osteotomy.
Study NCT05548049 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bone harvesting from ramus area with conventional burs for autogenous bone augmentation
Description: In control group, After the full-thickness flap is lifted with the periosteal elevator, using a thin #9 fissure burand the surgical handpiece S-11 Straight tip , the physiodispenser settings are according to the manufacturer's recommendations. The osteotomy was performed after it was adjusted to 40,000 rpm as appropriate. Bone incisions were completed with a round bur to combine the lower horizontal osteotomies and 2 vertical osteotomies. The osteotomies were completed with the help of a thin flat drill, and the block graft was carefully separated from the donor site.
Study NCT05820698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Mediterranean style diet
Description: Participants in the Mediterranean style diet group will be provided with recommendations to include a minimum of 5 servings of fruits and vegetables (combined) per day, 2 servings of whole grains per meal per day, at least two servings of extra virgin olive oil per day, a maximum two servings of dairy products per day (excluding milk in coffee/tea), a minimum of 3 servings of fish per week (of which two should be oily fish), less than 2 servings of red meat or processed meat per week. Confectionary and sugar sweetened beverages should be limited to less than 2 servings per week.~Participants randomised to the Mediterranean style intervention will be provided with support documents including a dietary guideline booklet, recipes, meal plans, shopping and product swap lists, as well as eating-out and budget-eating advice sheets. Food deliveries containing key food items of the diet intervention will be scheduled for week 1, week 4, and week 8 of the study.
Study NCT04395521 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetic foot self-management support
Description: Daily educational organic or inorganic posts (2 to 5) released in a timed sequence through a Hootsuite application plus peer interactions/support for three months.